DGX
Quest Diagnostics Incorporated
Healthcare
$193.82
as of May 21, 2026
Sign in to add DGX to your portfolio.
Sign inMarket cap
$21.45B
P/E (TTM)
20.8x
EPS (TTM)
$9.31
Dividend yield
1.68%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $10.79B | $2.00B | $1.83B | 39.0% | 22.1% | $15.90 |
| 2022 | $9.88B | $946.00M | $1.31B | 34.7% | 14.4% | $8.12 |
| 2023 | $9.25B | $854.00M | $864.00M | 33.2% | 13.6% | $7.59 |
| 2024 | $9.87B | $871.00M | $909.00M | 32.9% | 13.6% | $7.80 |
| 2025 | $11.04B | $992.00M | $1.36B | 31.9% | 14.5% | $8.87 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $192.73 | $193.82 | 473.95K |
| May 20, 2026 | $191.87 | $193.75 | 948.66K |
| May 19, 2026 | $189.24 | $190.39 | 782.45K |
| May 18, 2026 | $187.64 | $189.84 | 926.13K |
| May 15, 2026 | $189.16 | $186.61 | 1.08M |
| May 14, 2026 | $190.92 | $187.94 | 768.10K |
| May 13, 2026 | $188.81 | $190.85 | 693.15K |
| May 12, 2026 | $191.21 | $190.18 | 754.93K |
| May 11, 2026 | $187.36 | $189.81 | 620.70K |
| May 08, 2026 | $191.71 | $187.39 | 762.52K |
| May 07, 2026 | $188.19 | $190.84 | 739.97K |
| May 06, 2026 | $190.89 | $189.13 | 898.64K |
| May 05, 2026 | $191.39 | $190.84 | 613.83K |
| May 04, 2026 | $190.61 | $191.50 | 567.50K |
| May 01, 2026 | $194.50 | $192.67 | 692.00K |
| Apr 30, 2026 | $190.24 | $194.20 | 1.11M |
| Apr 29, 2026 | $193.85 | $189.32 | 1.40M |
| Apr 28, 2026 | $198.59 | $195.05 | 909.13K |
| Apr 27, 2026 | $195.91 | $196.63 | 702.93K |
| Apr 24, 2026 | $199.99 | $196.27 | 1.04M |
| Apr 23, 2026 | $205.28 | $199.53 | 1.26M |
| Apr 22, 2026 | $205.37 | $204.00 | 1.61M |
| Apr 21, 2026 | $203.25 | $205.04 | 2.43M |
| Apr 20, 2026 | $194.22 | $196.31 | 1.96M |
Profitability & balance
- ROE (TTM)
- 14.1%
- Gross margin
- 33.2%
- Operating margin
- 14.3%
- Net margin
- 9.1%
- Debt / equity
- 0.95